Gender differences and pregnant women in a Methadone Maintenance Treatment (MMT) clinic

Journal of Addictive Diseases

Volumn 25, Issue 2, 2006, Pages 39-45

  Peles, Einat ^a   Adelson, Miriam ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Gender differences; Methadone maintenance; Opiates; Pregnant women

Indexed keywords

COCAINE; METHADONE; OPIATE;

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; FISHER EXACT TEST; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; PREGNANT WOMAN; SEX DIFFERENCE; SEX RATIO; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; URINALYSIS;

ADULT; AGE FACTORS; COCAINE-RELATED DISORDERS; COHORT STUDIES; COMORBIDITY; EMIGRATION AND IMMIGRATION; FEMALE; HUMANS; ISRAEL; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; PATIENT ADMISSION; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; SEX FACTORS; SOCIOECONOMIC FACTORS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 33746650108     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v25n02_06     Document Type: Article

References (29)

1. Brady KT, Randall CL. Gender Differences in Substance Use Disorders. Psychiatr. Clin. North. Am. 1999;22:241-2.
2. Grella CE, Joshi V. Gender Differences in Drug Treatment Careers Among Clients in The National Drug Abuse Treatment Outcome Study. Am. J. Drug Alcohol Abuse. 1999;25:385-406.
3. Davis TM, Carpenter KM, Malte CA, Carney M, Chambers S, Saxon AJ. Women in Addictions Treatment: Comparing V A and Community Samples. J. Subst. Abuse Treat. 2002;23:41-8.
4. Magura S, Nwakeze PC, Demsky SY. Pre- and In-Treatment Predictors of Retention in Methadone Treatment Using Survival Analysis. Addiction. 1998;93: 51-60.
5. Hser YI, Anglin MD, Liu Y. A Survival Analysis of Gender and Ethnic Differences in Responsiveness to Methadone Maintenance Treatment. Int. J. Addict. 1990;25:1295-315.
6. Schottenfeld RS, Pakes JR, Kosten TR. Prognostic Factors in Buprenorphine-Versus Methadone-Maintained Patients. J. Nerv. Ment. Dis. 1998;186:35-43.
7. McCaul ME, Svikis DS, Moore RD. Predictors of Outpatient Treatment Retention: Patient Versus Substance Use Characteristics. Drug Alcohol Depend. 2001;62:9-17.
8. Adelson MO, Hayward R, Bodner G, Bleich A, Gelkopf M, Kreek MJ. Replication of an Effective Opiate Addiction Pharmacotherapeutic Treatment Model: Minimal Need for Modification in a Different Country. Journal of Maintenance in the Addictions. 2000;1:5-13.
9. Hawks RL. Analytical methodology. NIDA Res Monogr. 1986;73:30-42.
10. Hosmer DW, Lemeshow SA. Goodness-of-Fit Test for the Multiple Logistic Regression Model. Comm Stat. 1980;A10:1043-69.
11. Bar-Hamburger R, Rahav G, Teichman M, Rosenblum I. Psychoactive Substance Abuse in Israel 2001. Epidemiological Survey. Israeli Antidrug Authority.
12. Cohen K, Kandel D. Relationship Between Extent of Cocaine Use and Dependence Among Adolescents and Adults in the United States. Drug Alcohol Depend. 2002;68:65-85.
13. Camacho LM, Bartholomew NG, Joe GW, Cloud MA, Simpson DD. Gender, Cocaine and During-Treatment HIV Risk Reduction Among Injection Opioid Users in Methadone Maintenance. Drug Alcohol Depend. 1996;41:1-7.
14. Magura S, Kang SY, Nwakeze PC, Demsky S. Temporal Patterns of Heroin and Cocaine Use Among Methadone Patients. Subst. Use Misuse. 1998;33:2441-67.
15. Isralowitz R, Bar-Hamburger R. Immigrant and Native-Born Female Heroin Addicts in Israel. J. Psychoactive Drugs. 2002;34:97-103.
16. Green CA, Polen MR, Dickinson DM, Lynch FL, Bennett MD. Gender Differences in Predictors of Initiation, Retention, and Completion in an HMO-Based Substance Abuse Treatment Program. J. Subst. Abuse Treat. 2002;23:285-5.
17. Kletter E. Counseling As an Intervention for the Cocaine-Abusing Methadone Maintenance Patient. J. Psychoactive Drugs. 2003;35:271-7.
18. Kreek MJ. Using Methadone Effectively: Achieving Goals by Application of Laboratory, Clinical, and Evaluation Research and by Development of Innovative Programs. NIDA Res Monogr. 1991;106:245-66.
19. Ochshorn M, Bodner G, Novick DM, Kreek MJ. The Effect of Methadone In Vitro on Natural Killer (NK) Activity. NIDA Res. Monogr. 1989;95:522-3.
20. Heesch CM, Negus BH, Bost JE, Keffer JH, Snyder RW 2nd, Eichhorn EJ. Effects of Cocaine on Anterior Pituitary and Gonadal Hormones. J. Pharmacol. Exp. Ther. 1996;278:1195-200.
21. Rome ES, Rybicki LA, Durant RH. Pregnancy and Other Risk Behaviors Among Adolescent Girls in Ohio. J. Adolesc. Health. 1998;22:50-5.
22. Little BB, Snell LM, Van-Beveren TT, Crowell RB, Trayler S, Johnston WL. Treatment of Substance Abuse During Pregnancy and Infant Outcome. Am. J. Perinatol. 2003;20:255-62.
23. Ebrahim SH, Gfroerer J. Pregnancy-Related Substance Use in the United States During 1996-1998. Obstet. Gynecol. 2003;101:374-9.
24. Weber AE, Tyndall MW, Spittal PM, Li K, Coulter S, O'Shaughnessy MV, Schechter MT. High Pregnancy Rates and Reproductive Health Indicators Among Female Injection-Drug Users in Vancouver, Canada. Eur. J. Contracept. Reprod. Health Care. 2003;8:52-8.
25. Guerriero FJ, Fox KA. Benzodiazepine-Induced Suppression of Estrous Cycles in C57BL/6J Mice. Res. Commun. Chem. Pathol. Pharmacol. 1975;11: 155-8.
26. Kogo H, Iida H, Taya K, Sasamoto S, Inazu N, Satoh T. Mode of Action of Chlorpromazine (CPZ) Blockage on 13,14-Dihydroprostaglandin F2-Alpha Formation in Rat Ovary. Prostaglandins Leukot. Med. 1987;29:153-63.
27. Inazu N, Hayashi M, Hiur M, Satoh T. Effects of Psychotropic Drugs on Aldo-Keto Reductase Activity in Rat Ovary and Adrenal Gland. Biochem. Pharmacol. 1996;52:1585-91.
28. Alleva JJ, Alleva FR. Synergistic Inhibition by Benzodiazepine and Barbiturate Drugs of the Clock Control of Ovulation in Hamsters. Chronobiol. Int. 1995;12:1-7.
29. Judd SJ, Wong J, Saloniklis S, Maiden M, Yeap B, Filme S, Michailov L. The Effect of Alprazolam on Serum Cortisol and Luteinizing Hormone Pulsatility in Normal Women and in Women with Stress-Related Anovulation. J. Clin. Endocrinol. Metab. 1995;80:818-23.